Institution · Servier (France)
Most cited papers from Servier (France)
What are the most cited papers from Servier (France)?
The most cited paper from Servier (France) is "International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels" (William A. Catterall, K. George Chandy, David E. Clapham et al., 2003), with 7,147 citations. Next come "Descending control of pain" (3,055) and "Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study" (2,576).
Showing 50 of 60 papers. Every paper with more than 439 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels William A. Catterall, K. George Chandy, David E. Clapham et al. · Pharmacological Reviews | Dec 2003 | 7,147 |
| 2 | Descending control of pain Mark John Millan · Progress in Neurobiology | Apr 2002 | 3,055 |
| 3 | Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study Karl B Swedberg, Michel Komajda, Michael C Böhm et al. · The Lancet | 31 Aug 2010 | 2,576 |
| 4 | iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics Lesley Seymour, Jan Bogaerts, Andrea Marie Perrone et al. · The Lancet Oncology | Mar 2017 | 2,506 |
| 5 | RECIST 1.1—Update and clarification: From the RECIST committee Lawrence Howard Schwartz, Saskia Litière, Elisabeth G.E. de Vries et al. · European Journal of Cancer | 14 May 2016 | 1,949 |
| 6 | AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice Li Yu, Shanqin Xu, Maria M. Mihaylova et al. · Cell Metabolism | Apr 2011 | 1,787 |
| 7 | The induction of pain: an integrative review Mark John Millan · Progress in Neurobiology | 1999 | 1,777 |
| 8 | Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy Mark John Millan et al. · Nature Reviews Drug Discovery | Feb 2012 | 1,319 |
| 9 | Endothelial dysfunction in diabetes An S. De Vriese, Tony J. Verbeuren, Johan Van de Voorde et al. · British Journal of Pharmacology | Jul 2000 | 1,168 |
| 10 | Functional Selectivity and Classical Concepts of Quantitative Pharmacology Jonathan D. Urban, William P. Clarke, Mark von Zastrow et al. · Journal of Pharmacology and Experimental Therapeutics | 28 Jun 2006 | 1,126 |
| 11 | Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial Michael C Böhm, Karl B Swedberg, Michel Komajda et al. · The Lancet | 31 Aug 2010 | 1,107 |
| 12 | Functional and physical interaction between Bcl‐XL and a BH3‐like domain in Beclin‐1 Maria Chiara Maiuri, Gaëtane Le Toumelin, Alfredo Criollo et al. · The EMBO Journal | 19 Apr 2007 | 1,095 |
| 13 | The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models András Kotschy et al. · Nature | Oct 2016 | 1,079 |
| 14 | A dynamic COVID-19 immune signature includes associations with poor prognosis Adam G. Laing et al. · Nature Medicine | 17 Aug 2020 | 1,037 |
| 15 | Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing Stephen C. Cunnane et al. · Nature Reviews Drug Discovery | 24 Jul 2020 | 1,037 |
| 16 | The CCP 4 suite: integrative software for macromolecular crystallography Jon Agirre et al. · Acta Crystallographica Section D Structural Biology | 4 May 2023 | 945 |
| 17 | Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure Sonia H Shah et al. · Nature Communications | 9 Jan 2020 | 944 |
| 18 | Endothelial dysfunction and vascular disease - a 30th anniversary update Paul M. Vanhoutte, Hiroaki Shimokawa, Michel Félétou et al. · Acta Physiologica | 26 Dec 2015 | 942 |
| 19 | Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock* Ángel Crespo López, Jose Angel Lorente, Jay S. Steingrub et al. · Critical Care Medicine | 2004 | 925 |
| 20 | EDHF: bringing the concepts together Rudi Busse, Gillian Edwards, Michel Félétou et al. · Trends in Pharmacological Sciences | Aug 2002 | 814 |
| 21 | Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture) Michel Félétou, Paul M. Vanhoutte · American Journal of Physiology-Heart and Circulatory Physiology | 21 Apr 2006 | 812 |
| 22 | Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma Ingo K. Mellinghoff et al. · New England Journal of Medicine | 4 Jun 2023 | 806 |
| 23 | Endothelial dysfunction and vascular disease Paul M. Vanhoutte, Hiroaki Shimokawa, Eva H.C. Tang et al. · Acta Physiologica | 19 Mar 2009 | 800 |
| 24 | SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase Xiuyun Hou, Shanqin Xu, Karlene A. Maitland-Toolan et al. · Journal of Biological Chemistry | 15 May 2008 | 784 |
| 25 | Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system Antoine Taly, Pierre‐Jean Corringer, Denis Guédin et al. · Nature Reviews Drug Discovery | Sep 2009 | 700 |
| 26 | Electronic health records to facilitate clinical research Martín Cowie, Juuso Blomster, Lesley H. Curtis et al. · Clinical Research in Cardiology | 23 Aug 2016 | 692 |
| 27 | Overview of Nomenclature of Nuclear Receptors Pierre Germain, Bart Staels, Catherine Dacquet et al. · Pharmacological Reviews | 28 Nov 2006 | 677 |
| 28 | International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology Richard R. Neubig, Michael Spedding, Terry Kenakin et al. · Pharmacological Reviews | Dec 2003 | 671 |
| 29 | Polyphenols Stimulate AMP-Activated Protein Kinase, Lower Lipids, and Inhibit Accelerated Atherosclerosis in Diabetic LDL Receptor–Deficient Mice Mengwei Zang, Shanqin Xu, Karlene A. Maitland-Toolan et al. · Diabetes | 27 Jul 2006 | 663 |
| 30 | Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure John R. Teerlink et al. · New England Journal of Medicine | 13 Nov 2020 | 662 |
| 31 | Genetic drug target validation using Mendelian randomisation Amand Floriaan Schmidt, Chris Finan, María Gordillo‐Marañón et al. · Nature Communications | 26 Jun 2020 | 637 |
| 32 | International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors Margarita L. Dubocovich, Philippe Delagrange, Diana N. Krause et al. · Pharmacological Reviews | 17 Aug 2010 | 627 |
| 33 | Report from the in vitro micronucleus assay working group Micheline Kirsch‐Volders, Toshio Sofuni, Marilyn J. Aardema et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis | 22 Sep 2003 | 627 |
| 34 | International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List Steven M. Foord, Tom I. Bonner, Richard R. Neubig et al. · Pharmacological Reviews | 24 May 2005 | 620 |
| 35 | Identification of the Melatonin-binding SiteMT 3 as the Quinone Reductase 2 Olivier Nosjean, Myriam Ferro, Francis Cogé et al. · Journal of Biological Chemistry | Oct 2000 | 603 |
| 36 | A nomenclature for ligand-gated ion channels Graham L. Collingridge, Richard W. Olsen, John A. Peters et al. · Neuropharmacology | 7 Jul 2008 | 597 |
| 37 | Agomelatine, the first melatonergic antidepressant: discovery, characterization and development Christian de Bodinat, Béatrice Guardiola-Lemaı̂tre, Elisabeth Mocaër et al. · Nature Reviews Drug Discovery | 25 Jun 2010 | 592 |
| 38 | Incorporation and distribution of strontium in bone Svein G. Dahl, Philippe Allain, Pierre J. Marie et al. · Bone | Apr 2001 | 588 |
| 39 | Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing Barry Boland, Wai Haung Yu, Olga Corti et al. · Nature Reviews Drug Discovery | 17 Aug 2018 | 570 |
| 40 | A compact review of molecular property prediction with graph neural networks Oliver Wieder, Stefan M. Kohlbacher, Mélaine A. Kuenemann et al. · Drug Discovery Today Technologies | Dec 2020 | 543 |
| 41 | Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial Marc P.E. André et al. · Journal of Clinical Oncology | 14 Mar 2017 | 539 |
| 42 | The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways Mark John Millan, Alain P. Gobert, Françoise Lejeune et al. · Journal of Pharmacology and Experimental Therapeutics | 19 Aug 2003 | 517 |
| 43 | Endothelium-Dependent Hyperpolarization Richard Alan Cohen, Paul M. Vanhoutte · Circulation | Dec 1995 | 517 |
| 44 | Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial Anthony L. Traboulsee, Benjamin M. Greenberg, Jeffrey L. Bennett et al. · The Lancet Neurology | 22 Apr 2020 | 514 |
| 45 | Ivosidenib and Azacitidine in IDH1 -Mutated Acute Myeloid Leukemia Pau Montesinos, Christian Récher, Susana Pons Vives et al. · New England Journal of Medicine | 20 Apr 2022 | 512 |
| 46 | When poor solubility becomes an issue: From early stage to proof of concept Sven Stegemann, Franck Leveiller, Dionigio Franchi et al. · European Journal of Pharmaceutical Sciences | 25 May 2007 | 511 |
| 47 | Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial Stuart L. Silverman, Claus Christiansen, Harry K. Genant et al. · Journal of Bone and Mineral Research | 29 Jul 2008 | 507 |
| 48 | Endothelial Dysfunction: From Physiology to Therapy Jean‐Vivien Mombouli, Paul M. Vanhoutte · Journal of Molecular and Cellular Cardiology | 1999 | 500 |
| 49 | Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors Andrew R. Reynolds, Ian R. Hart, Alan R. Watson et al. · Nature Medicine | 22 Mar 2009 | 488 |
| 50 | Prevention of Psychosis Paolo Fusar‐Poli, Gonzalo Salazar de Pablo, Christoph Ulrich Correll et al. · JAMA Psychiatry | 11 Mar 2020 | 481 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.